GCA relapse on steroids — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Tocilizumab
Tocilizumab is the targeted biologic most appropriate for this refractory vasculitis phenotype. The alternatives either target a different pathway or lack the same role in this vasculitis scenario. Biologic choice in vasculitis is driven by subtype, organ involvement, relapse pattern and steroid toxicity.
Reference: BSR giant cell arteritis guideline; EULAR large-vessel vasculitis recommendations; BNF